ICICI Direct's research report on Sudarshan Chemical Industries
Q2FY21 revenues grew 1% YoY, 21.7% QoQ to Rs 428.9 crore. Pigment segment grew mere 0.4% YoY, 17.8% QoQ to Rs 402 crore. Muted YoY growth was mainly due to production disruption in July amid Covid-19. EBITDA margins improved mere 18 bps YoY to 15.8% (I-direct estimate: 15.5%), 111 bps improvement in gross margins was largely offset by higher employee cost and other expenditure. EBITDA grew 2.1% YoY, 27.8% QoQ to Rs 67.7 crore vs. I-direct estimate of Rs 63.3 crore. PAT declined 34.4% YoY (up 66.7% YoY) to Rs 30.3 crore (I-direct estimate: Rs 27.3 crore) due to increase in depreciation, interest cost and tax outgo.
Outlook
Margins are also likely to improve due to backward integration, change in product mix towards margin accretive products. We have a BUY rating with a target price of Rs 550 (22x FY23E EPS of Rs 25).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.